Transaction in Own Shares
Rhea-AI Summary
Shell (SHEL) bought 1,477,210 shares for cancellation on 18 November 2025 as part of its on- and off-market buy-back programme announced 30 October 2025. Purchases were executed on LSE and XAMS with aggregated volume-weighted average prices of £28.1638 (LSE) and €32.0662 (XAMS); highest prices paid were £28.40 and €32.34 respectively.
Merrill Lynch International is making trading decisions independently for the programme period 30 October 2025 to 30 January 2026. The buy-back is conducted under UK MAR and related rules; a detailed trade breakdown by Merrill Lynch is provided.
Positive
- Shares purchased: 1,477,210 on 18 November 2025
- LSE VWAP: £28.1638 and XAMS VWAP: €32.0662
- Buy-back executed under existing shareholder-approved authorities
Negative
- Highest prices paid reached £28.40 and €32.34
- Trading decisions delegated to Merrill Lynch International until 30 January 2026
News Market Reaction
On the day this news was published, SHEL declined 0.12%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Transaction in Own Shares
18 November, 2025
• • • • • • • • • • • • • • • •
Shell plc (the ‘Company’) announces that on 18 November, 2025 it purchased the following number of Shares for cancellation.
Aggregated information on Shares purchased according to trading venue:
| Date of purchase | Number of Shares purchased | Highest price paid | Lowest price paid | Volume weighted average price paid per share | Venue | Currency |
| 18/11/2025 | 740,412 | 28.4000 | 27.9950 | 28.1638 | LSE | GBP |
| 18/11/2025 | - | - | - | - | Chi-X (CXE) | GBP |
| 18/11/2025 | - | - | - | - | BATS (BXE) | GBP |
| 18/11/2025 | 736,798 | 32.3400 | 31.8800 | 32.0662 | XAMS | EUR |
| 18/11/2025 | - | - | - | - | CBOE DXE | EUR |
| 18/11/2025 | - | - | - | - | TQEX | EUR |
These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 30 October 2025.
In respect of this programme, Merrill Lynch International will make trading decisions in relation to the securities independently of the Company for a period from 30 October 2025 up to and including 30 January 2026.
The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.
In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Merrill Lynch International on behalf of the Company as a part of the buy-back programme is detailed below.
Enquiries
Media: International +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html
Attachment